BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27358756)

  • 1. Safety concerns over the use of intestinal permeation enhancers: A mini-review.
    McCartney F; Gleeson JP; Brayden DJ
    Tissue Barriers; 2016; 4(2):e1176822. PubMed ID: 27358756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
    Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
    Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
    Kneiszl R; Hossain S; Larsson P
    Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
    Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
    Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
    Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C
    Twarog C; Fattal E; Noiray M; Illel B; Brayden DJ; Taverna M; Hillaireau H
    Int J Pharm; 2022 Oct; 626():122131. PubMed ID: 36028084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
    Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
    Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labrasol
    Heade J; Maher S; Bleiel SB; Brayden DJ
    J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAC for Enhanced Oral Bioavailability: An Updated Review.
    Kommineni N; Sainaga Jyothi VGS; Butreddy A; Raju S; Shapira T; Khan W; Angsantikul P; Domb AJ
    Pharm Res; 2023 Mar; 40(3):633-650. PubMed ID: 36539668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
    Maher S; Leonard TW; Jacobsen J; Brayden DJ
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of C10 and SNAC erodible tablets for gastric delivery of a GIP/GLP1 peptide in monkeys.
    Tran H; Dogra M; Huang S; Aihara E; ElSayed M; Aburub A
    Int J Pharm; 2024 Jan; 650():123680. PubMed ID: 38070657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
    Hess S; Rotshild V; Hoffman A
    Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
    Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
    Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of colonic drug absorption by the transcellular permeation route.
    Tomita M; Hayashi M; Horie T; Ishizawa T; Awazu S
    Pharm Res; 1988 Dec; 5(12):786-9. PubMed ID: 3247289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
    Fan D; Wu X; Dong W; Sun W; Li J; Tang X
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1447-56. PubMed ID: 23020091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.
    Nakaya Y; Takaya M; Hinatsu Y; Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    J Pharm Sci; 2016 Dec; 105(12):3680-3690. PubMed ID: 27771051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal permeation enhancers for oral peptide delivery.
    Maher S; Mrsny RJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.